Skip to content

DEROPHARMA

Active Private limited companyfounded 2025active for 1 yearAvenue des Frères Fleischman 7, 1410 WaterlooKBO/BCE: BE 1021.522.440
DEROPHARMA
Follow ReportCompare

Board

1 director, since incorporation
DE ROP Sébastien
Director (not named in the articles)
since 26-03-2025 term without a fixed end
listed in the 2025 annual accounts, filed on 24-06-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
DE ROP Sébastien
Director (not named in the articles)
Board
Mandates as a list
  • DE ROP Sébastien
    • Director (not named in the articles), from 26-03-2025 to date

Control

Founder
DE ROP Sébastien
This company
DEROPHARMA
Equity €18,263
Profit €14,263 in 2025

Capital

Contribution
€4,000
Shares
100
Contribution per share
€40
Equity per share
€183 in 2025
Source
2025 annual accounts

Articles of association

deed of 28-03-2025 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
“Un ou plusieurs administrateurs,personnes physiques ou morales, assemblée fixe nombre,durée et,en cas de pluralité,pouvoirs”
“Mandats, administrateur peut déléguer pouvoirs spéciaux et limités à tout mandataire”

Shareholders

At incorporation deed of 28-03-2025 ↗

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure